Treatment of postmenopausal osteoporosis with transdermal estrogen.

Lufkin, E G; Wahner, H W; O'Fallon, W M; Hodgson, S F; Kotowicz, M A; Lane, A W; Judd, H L; Caplan, R H; Riggs, B L

Lufkin, E G; Wahner, H W; O'Fallon, W M; Hodgson, S F; Kotowicz, M A; Lane, A W; Judd, H L; Caplan, R H; Riggs, B L.

Affiliation

Lufkin EG; Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, MN 55905.

Ann Intern Med ; 117(1): 1-9, 1992 Jul 01.

Article in En | MEDLINE | ID: mdl-1534476

Subject(s)

Estradiol/administration & dosage; Osteoporosis, Postmenopausal/drug therapy; Administration, Cutaneous; Administration, Oral; Aged; Bone Density/drug effects; Double-Blind Method; Drug Therapy, Combination; Estradiol/adverse effects; Estradiol/blood; Estrone/blood; Female; Humans; Medroxyprogesterone/administration & dosage; Medroxyprogesterone/analogs & derivatives; Medroxyprogesterone Acetate; Middle Aged; Osteoporosis, Postmenopausal/complications; Prospective Studies; Spinal Fractures/etiology; Spinal Fractures/prevention & control

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis, Postmenopausal / Estradiol Type of study: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Ann Intern Med Year: 1992 Document type: Article

Search on Google

XML

PubMed Links